YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels

References

• Weir EK, Lopez-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing mechanisms. N Engl J Med 2005;353:2042–55
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Rabinovitch M. Emerging therapies for the treatment of pulmonary hypertension. Pediatr Crit Care Med 2010;11:S85–90
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99:675–91
   PubMed Web of Science ®Google Scholar
• Jurasz P, Courtman D, Babaie S, Stewart DJ. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials. Pharmacol Ther 2010;126:1–8
   PubMed Web of Science ®Google Scholar
• Michelakis ED, Wilkins MR, Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 2008;118:1486–95
   PubMed Web of Science ®Google Scholar
• Archer SL, Michelakis ED. An evidence-based approach to the management of pulmonary arterial hypertension. Curr Opin Cardiol 2006;21:385–92
   PubMed Web of Science ®Google Scholar
• Sommer N, Dietrich A, Schermuly RT, et al. Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms. Eur Respir J 2008;32:1639–51
   PubMed Web of Science ®Google Scholar
• Park WS, Firth AL, Han J, Ko EA. Patho-, physiological roles of voltage-dependent K+ channels in pulmonary arterial smooth muscle cells. J Smooth Muscle Res 2010;46:89–105
   PubMedGoogle Scholar
• Remillard CV, Yuan JX. Activation of K+ channels: an essential pathway in programmed cell death. Am J Physiol Lung Cell Mol Physiol 2004;286:L49–67
   PubMed Web of Science ®Google Scholar
• Post JM, Hume JR, Archer SL, Weir EK. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol 1992;262:C882–90
   PubMed Web of Science ®Google Scholar
• Moudgil R, Michelakis ED, Archer SL. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation 2006;13:615–32
   PubMed Web of Science ®Google Scholar
• Ryan BM, O'Donovan N, Duffy MJ. Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 2009;35:553–62
   PubMed Web of Science ®Google Scholar
• Sah NK, Khan Z, Khan GJ, Bisen PS. Structural, functional and therapeutic biology of survivin. Cancer Lett 2006;244:164–71
   PubMed Web of Science ®Google Scholar
• Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008;8:61–70
   PubMed Web of Science ®Google Scholar
• Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007;28:1133–9
   PubMed Web of Science ®Google Scholar
• Guha M, Altieri DC. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 2009;8:2708–10
   PubMed Web of Science ®Google Scholar
• Adnot S. Lessons learned from cancer may help in the treatment of pulmonary hypertension. J Clin Invest 2005;115:1461–3
   PubMed Web of Science ®Google Scholar
• Altieri DC. Targeting survivin in cancer. Cancer Lett 2013;332:225–8
   PubMed Web of Science ®Google Scholar
• Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003;3:46–54
   PubMed Web of Science ®Google Scholar
• Dohi T, Beltrami E, Wall NR, et al. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 2004;114:1117–27
   PubMed Web of Science ®Google Scholar
• McMurtry MS, Archer SL, Altieri DC, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005;115:1479–91
   PubMed Web of Science ®Google Scholar
• Yamanaka K, Nakata M, Kaneko N, et al. YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer. Int J Oncol 2011;39:569–75
   PubMed Web of Science ®Google Scholar
• Church DN, Talbot DC. Survivin in solid tumors: rationale for development of inhibitors. Curr Oncol Rep 2012;14:120–8
   PubMed Web of Science ®Google Scholar
• Ghadimi MP, Young ED, Belousov R, et al. Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors. Clin Cancer Res 2012;18:2545–57
   PubMed Web of Science ®Google Scholar
• Lu W, Ran P, Zhang D, et al. Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle. Am J Physiol Cell Physiol 2010;298:C114–23
   PubMed Web of Science ®Google Scholar
• Nakahara T, Kita A, Yamanaka K, et al. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res 2007;67:8014–21
   PubMed Web of Science ®Google Scholar
• Sun P, Liu WL. Method for measuring the pulmonary artery pressure with a right cardiac catheter in rats. Acta Acad Med Sin 1984;6:465–7 (in Chinese)
   Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45
   PubMed Web of Science ®Google Scholar
• Zhu XF, Liu ZC, Xie BF, et al. Involvement of caspase-3 activation in squamocin-induced apoptosis in leukemia cell line HL-60. Life Sci 2002;70:1259–69
   PubMed Web of Science ®Google Scholar
• McMurtry MS, Bonnet S, Wu X, et al. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 2004;95:830–40
   PubMed Web of Science ®Google Scholar
• Communal C, Sumandea M, de Tombe P, et al. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:6252–6
   PubMed Web of Science ®Google Scholar
• Platoshyn O, Golovina VA, Bailey CL, et al. Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. Am J Physiol Cell Physiol 2000;279:C1540–9
   PubMed Web of Science ®Google Scholar
• Hu HL, Zhang ZX, Chen CS, et al. Effects of mitochondrial potassium channel and membrane potential on hypoxic human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 2010;42:661–6
   PubMed Web of Science ®Google Scholar
• Chen C, Chen C, Wang Z, et al. Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells. PLoS One 2012;7:e34181
   PubMed Web of Science ®Google Scholar
• Dromparis P, Sutendra G, Michelakis ED. The role of mitochondria in pulmonary vascular remodeling. J Mol Med (Berl) 2010;88:1003–10
   PubMed Web of Science ®Google Scholar